180 Life Sciences Corp.

As of May 1, 2025, the market trend is mildly bearish, influenced by daily moving averages and Bollinger Bands, despite some mildly bullish signals from weekly and monthly indicators, suggesting a cautious approach.

180 Life Sciences Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $5.29 million. Key metrics include a negative P/E ratio, no dividend yield, and a price-to-book ratio of 0.69.

As of Jun 18, 180 Life Sciences Corp. has a market capitalization of 5.29 million, with net sales of 0.00 million and a net profit of -7.47 million. Shareholder's funds were 9.25 million, and total assets amounted to 33.51 million.